Your browser doesn't support javascript.
loading
Single-cell characterization of anti-LAG-3 and anti-PD-1 combination treatment in patients with melanoma.
Huuhtanen, Jani; Kasanen, Henna; Peltola, Katriina; Lönnberg, Tapio; Glumoff, Virpi; Brück, Oscar; Dufva, Olli; Peltonen, Karita; Vikkula, Johanna; Jokinen, Emmi; Ilander, Mette; Lee, Moon Hee; Mäkelä, Siru; Nyakas, Marta; Li, Bin; Hernberg, Micaela; Bono, Petri; Lähdesmäki, Harri; Kreutzman, Anna; Mustjoki, Satu.
Afiliação
  • Huuhtanen J; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
  • Kasanen H; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Peltola K; Department of Computer Science, Aalto University, Espoo, Finland.
  • Lönnberg T; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.
  • Glumoff V; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
  • Brück O; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Dufva O; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.
  • Peltonen K; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.
  • Vikkula J; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Jokinen E; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
  • Ilander M; Research Unit of Biomedicine, Medical Microbiology and Immunology, University of Oulu, Oulu, Finland.
  • Lee MH; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
  • Mäkelä S; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Nyakas M; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.
  • Li B; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
  • Hernberg M; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Bono P; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.
  • Lähdesmäki H; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
  • Kreutzman A; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Mustjoki S; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.
J Clin Invest ; 133(6)2023 03 15.
Article em En | MEDLINE | ID: mdl-36719749
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Melanoma / Antineoplásicos Limite: Humans Idioma: En Revista: J Clin Invest Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Finlândia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Melanoma / Antineoplásicos Limite: Humans Idioma: En Revista: J Clin Invest Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Finlândia